By Next Frontier Holdings, Inc. Defendants: Dr. Sud Agarwal, Todd C. Davis, Murchinson Ltd., and Marilynn D. Martin
|
 | By Greater Gift Pharmaceutical Business Conference Group, a specialist events organiser dedicated to creating meaningful clinical trial conferences in the pharmaceutical and biotech space, today announced a new strategic partnership with Greater Gift, a leading...
|
By The 505b2 Platform Free conference will focus on New Horizons in Value-added Medicines development and commercialization in the US and globally.
|
By Aixial Group Following its acquisition of Larix in 2019 and Cmed Group in 2021, Aixial Group has become a leading mid-size, global CRO, with strong US and European presence and more than 1,000 employees.
|
By MDR Specialty Pharmacy MDR Specialty Pharmacy, the nation's leading independent fertility pharmacy, has completed the acquisition of Barron Pharmacy, based in Beachwood, Ohio.
|
 | By Nova Biomedical Nova Biomedical is pleased to announce the launch of BioProfile FAST CDV, a high-throughput, fully automated viable cell density and viability analyzer capable of producing results in under 70 seconds with just 100μL of sample volume.
|
By RealRate GmbH The new Pharma ratings for 2022 have just been released by RealRate.
|
 | By Sirona Biochem Corp. Allergan Aesthetics, a subsidiary of AbbVie Inc., a global biopharmaceutical company, has signed a licensing deal with Sirona Biochem (TSX-V: SBM).
|
By Pipelinepharma The leading European pharmaceutical marketplace now hosts more than 85 000 CTD dossiers for finished dosage formulation products. Compared to 19 600 products at the start of 2021, the product offering has increased fourfold over a single year.
|
By Akaal Tech and Agro Akaal Tech and Agro Pty Ltd (ATA) and Hb-22 today announced a collaboration to develop novel formulations including cannabidiol (CBD) and novel patented NSAIDs.
|
By SMi Group SMi Group reports: The 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference is set to return in May 2022
|
By GENINVO GENINVO a leading provider of life sciences product and business solutions organization, announced the launch of a Centre of Excellence for Data Science and Analytics (DSA CoE).
|
By Pipelinepharma The European B2B pharmaceutical marketplace closed a venture seed round led by Practica Capital. Iron Wolf Capital, Pandos and a group of angel investors also participated in the funding round.
|
